These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29865170)

  • 1. Factors Influencing the Clinical Presentation of Breakthrough Pain in Cancer Patients.
    Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Vellucci R; Mammucari M; Natoli S; Lazzari M; Dauri M; Adile C; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Palermo L; Mameli S; Masedu F; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; Pascoletti G; De Santis S; Orsetti R; Papa A; Ricci S; Scelzi E; Sofia M; Tonini G; Valle A; Aielli F;
    Cancers (Basel); 2018 Jun; 10(6):. PubMed ID: 29865170
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced
    Fan R; Li X; Yang S; Bu X; Chen Y; Wang Y; Qiu C
    Pain Res Manag; 2022; 2022():8943292. PubMed ID: 35463627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
    Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
    Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings.
    Mercadante S; Lazzari M; Reale C; Cuomo A; Fusco F; Marchetti P; Mediati RD; Chiurazzi B; Ciuffedra L; Caraceni A; Iaffaioli V; Luzzani M; Micheletto G; Papa A; Raffaeli W; Valle A; Caruso M; Di Costanzo F; Pinato G; Nardi F; Barni S; Natoli S; Mammucari M; Sabato AF; Dauri M;
    Clin J Pain; 2015 Mar; 31(3):214-21. PubMed ID: 25654429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain.
    Mercadante S; Maltoni M; Russo D; Adile C; Ferrera P; Rossi R; Rosati M; Casuccio A
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Breakthrough Pain and Its Impact on Quality of Life in Terminally Ill Cancer Patients.
    Gonella S; Sperlinga R; Sciannameo V; Dimonte V; Campagna S
    Integr Cancer Ther; 2019; 18():1534735419859095. PubMed ID: 31220961
    [No Abstract]   [Full Text] [Related]  

  • 8. Fentanyl buccal tablet.
    Messina J; Darwish M; Fine PG
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse-based monitoring and management of breakthrough pain in an acute pain relief and palliative care unit.
    Mercadante S; Prestia G; Casuccio A
    Hosp Pract (1995); 2016 Oct; 44(4):203-206. PubMed ID: 27477690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of breakthrough pain in patients with head and neck cancer: a cross-sectional study.
    Bhatnagar S; Upadhyay S; Mishra S
    J Palliat Med; 2010 Mar; 13(3):291-5. PubMed ID: 20078224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer.
    Hjermstad MJ; Kaasa S; Caraceni A; Loge JH; Pedersen T; Haugen DF; Aass N;
    BMJ Support Palliat Care; 2016 Sep; 6(3):344-52. PubMed ID: 27342412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics.
    Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
    J Opioid Manag; 2010; 6(2):97-108. PubMed ID: 20481174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain.
    Sperlinga R; Campagna S; Berruti A; Laciura P; Ginosa I; Paoletti S; Giuliano PL; Tucci M; Rosato R; Scagliotti GV; Saini A
    Eur J Pain; 2015 Aug; 19(7):881-8. PubMed ID: 25370838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study.
    Portenoy RK; Messina J; Xie F; Peppin J
    Curr Med Res Opin; 2007 Jan; 23(1):223-33. PubMed ID: 17207304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A New Therapeutic Approach for Cancer-Related Breakthrough Pain - Focused on Oral Transmucosal Fentanyl].
    Yomiya K; Kaneshima M; Kyosaka B; Warita E; Hosonuma R; Osato S
    Gan To Kagaku Ryoho; 2017 Apr; 44(4):289-293. PubMed ID: 28428506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients.
    Campagna S; Sperlinga R; Milo A; Sannuto S; Acquafredda F; Saini A; Gonella S; Berruti A; Scagliotti GV; Tampellini M
    Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30586878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of breakthrough pain.
    McCarberg BH
    Pain Med; 2007; 8 Suppl 1():S8-13. PubMed ID: 17280601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakthrough pain in patients with controlled or uncontrolled basal pain: an observational study.
    Gatti A; Gentili M; Baciarello M; Lazzari M; Marzi R; Palombo E; Sabato AF; Fanelli G
    Pain Res Manag; 2014; 19(6):e168-71. PubMed ID: 24945289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.
    Mercadante S; Prestia G; Casuccio A
    Curr Med Res Opin; 2013 Nov; 29(11):1527-32. PubMed ID: 23869428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.